Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Swissmedic expands on existing multilateral agreement

This article was originally published in SRA

Executive Summary

A meeting between the national drug and device authorities of Switzerland ( Swissmedic), Australia ( Therapeutic Goods Administration), Canada ( Health Canada) and Singapore ( Health Sciences Authority) has served to intensify the existing collaboration among the countries1. The principal focus of a new co-operative agreement signed by the various bodies is on initiatives in the fields of marketing authorisation and market surveillance.

Advertisement
Advertisement
UsernamePublicRestriction

Register

PS114176

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel